Esperion Therapeutics Inc (ESPR)

10:55 AM

Dip Buying: Does Esperion Therapeutics Inc align with a passive investing strategy2026 Sector Moves & Free Reliable Trade Execution Plans - baoquankhu1.vn

10:55 AM

Mar 22, 2026

Esperion acquires Enbumyst maker Corstasis - MSN

Mar 22, 2026

Mar 22, 2026

Esperion (ESPR) highlights inclusion of bempedoic acid in 2026 ACC/AHA dyslipidemia guidelines - MSN

Mar 22, 2026

Mar 21, 2026

Esperion to acquire Corstasis for $75M upfront payment - MSN

Mar 21, 2026

Mar 21, 2026

Esperion Therapeutics prices $75M public offering - MSN

Mar 21, 2026

Mar 21, 2026

Esperion shares rise 8% after revenue tops forecasts and acquisition announced - MSN

Mar 21, 2026

Mar 20, 2026

Esperion (ESPR) Highlights Inclusion of Bempedoic Acid in 2026 ACC/AHA Dyslipidemia Guidelines - Insider Monkey

Mar 20, 2026

Mar 20, 2026

ESPR SEC FilingsEsperion Therape 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 20, 2026

Mar 20, 2026

ESPR Stock Price, Quote & Chart | ESPERION THERAPEUTICS INC (NASDAQ:ESPR) - ChartMill

Mar 20, 2026

Mar 19, 2026

ESPR's Q3 Earnings Lag Estimates, Revenues Rise Y/Y, Stock Down - MSN

Mar 19, 2026

Mar 18, 2026

Insider Selling: Esperion Therapeutics (NASDAQ:ESPR) Insider Sells $15,411.60 in Stock - MarketBeat

Mar 18, 2026

Mar 18, 2026

Esperion Therapeutics CFO Halladay sells $17k in stock By Investing.com - Investing.com India

Mar 18, 2026

Mar 18, 2026

Esperion Therapeutics CEO Koenig sells $69,546 in stock By Investing.com - Investing.com Canada

Mar 18, 2026

Mar 18, 2026

Esperion Therapeutics CFO Halladay sells $17k in stock - Investing.com

Mar 18, 2026

Mar 18, 2026

Esperion (NASDAQ: ESPR) CLO sells 5,708 shares to cover RSU tax bill - Stock Titan

Mar 18, 2026

Mar 18, 2026

Esperion Therapeutics (ESPR) CEO sells shares to pay RSU taxes - Stock Titan

Mar 18, 2026

Mar 18, 2026

Esperion (ESPR) CFO sells shares to cover taxes on vested RSUs - Stock Titan

Mar 18, 2026

Mar 18, 2026

Esperion outlines Vision 2040 with Corstasis acquisition and targets 2026 operating expenses up to $255M while expanding cardiometabolic portfolio - MSN

Mar 18, 2026

Mar 18, 2026

Esperion Therapeutics (NASDAQ:ESPR) Stock Price Down 7.6%Here's What Happened - MarketBeat

Mar 18, 2026

Mar 18, 2026

Q1 EPS Estimate for Esperion Therapeutics Lowered by Analyst - MarketBeat

Mar 18, 2026

Mar 18, 2026

Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM), Stryker (SYK) and Esperion (ESPR) - The Globe and Mail

Mar 18, 2026

Mar 17, 2026

ESPR (NASDAQ: ESPR) affiliate files to sell 6,424 vested shares after vesting - Stock Titan

Mar 17, 2026

Mar 17, 2026

ESPR (NASDAQ: ESPR) Form 144 files planned sale of 5,708 shares - Stock Titan

Mar 17, 2026

Mar 17, 2026

Sheldon Koenig to sell 25,578 ESPR shares (NASDAQ: ESPR) under Form 144 - Stock Titan

Mar 17, 2026

Mar 17, 2026

Esperion to Present Two New Analyses from CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session - Bitget

Mar 17, 2026

Mar 17, 2026

Esperion to Present Two New Analyses From CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session - 富途牛牛

Mar 17, 2026

Mar 17, 2026

CLEAR Outcomes trial findings to be presented by Esperion Therapeutics at major cardiology event - Traders Union

Mar 17, 2026

Mar 17, 2026

Bempedoic acid data spotlight statin-intolerant, autoimmune patients - Stock Titan

Mar 17, 2026

Mar 16, 2026

BofA reiterates Esperion Therapeutics stock Underperform rating By Investing.com - Investing.com Canada

Mar 16, 2026

Mar 16, 2026

Esperion Therapeutics (ESPR) CFO receives major equity grants - Stock Titan

Mar 16, 2026

Mar 16, 2026

Esperion (ESPR) CLO receives new stock and option grants - Stock Titan

Mar 16, 2026

Mar 16, 2026

[Form 4] Esperion Therapeutics, Inc. In... - Stock Titan

Mar 16, 2026

Mar 16, 2026

Esperion Therapeutics (NASDAQ:ESPR) Stock Price Up 7.8% Following Analyst Upgrade - MarketBeat

Mar 16, 2026

Mar 16, 2026

2026 cholesterol guideline backs bempedoic acid for statin-intolerant patients - Stock Titan

Mar 16, 2026

Mar 16, 2026

Esperion’s Bempedoic Acid Receives Multiple Class 1 Recommendations in 2026 ACC/AHA Multisociety Guideline for Management of Dyslipidemia - Sahm

Mar 16, 2026

Mar 15, 2026

Operating cash flow per share of Esperion Therapeutics, Inc. – DUS:0ET - TradingView

Mar 15, 2026

Mar 15, 2026

Esperion Therapeutics Touts 38% Revenue Growth, Corstasis Deal and 2026 Cash-Gen Path at Conference - MarketBeat

Mar 15, 2026

Mar 14, 2026

FTAI Aviation To Rally More Than 43%? Here Are 10 Top Analyst Forecasts For Friday - Sahm

Mar 14, 2026

Mar 14, 2026

Integral Health Asset Management LLC Purchases New Stake in Esperion Therapeutics, Inc. $ESPR - MarketBeat

Mar 14, 2026

Mar 14, 2026

Esperion Therapeutics (NASDAQ:ESPR) Upgraded to "Buy" at Wall Street Zen - MarketBeat

Mar 14, 2026

Mar 13, 2026

Esperion Therapeutics soars amid vague takeover speculation - MSN

Mar 13, 2026

Mar 13, 2026

Esperion Therapeutics (NASDAQ:ESPR) Price Target Raised to $5.00 - MarketBeat

Mar 13, 2026

Mar 13, 2026

Citizens raises Esperion Therapeutics price target on drug growth By Investing.com - Investing.com Canada

Mar 13, 2026

Mar 13, 2026

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Mar 13, 2026

Mar 12, 2026

Esperion Therapeutics (ESPR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan

Mar 12, 2026

Mar 12, 2026

Equities Analysts Issue Forecasts for ESPR Q1 Earnings - MarketBeat

Mar 12, 2026

Mar 11, 2026

Esperion Stock Pre-Market (-0.1%): EPS Miss Mutes Revenue Beat & Acquisition News - Trefis

Mar 11, 2026

Mar 11, 2026

ESPR's Q4 Earnings Lag Estimates, Revenues Beat, Stock Down - TradingView

Mar 11, 2026

Mar 11, 2026

Esperion at Citizens Life Sciences: Strategic Growth and Acquisition - Investing.com

Mar 11, 2026

Mar 11, 2026

What is HC Wainwright's Estimate for ESPR Q4 Earnings? - MarketBeat

Mar 11, 2026

Mar 11, 2026

Esperion Therapeutics (ESPR) Turns Q4 Profit As Bears Question Trailing Losses And Balance Sheet - Sahm

Mar 11, 2026

Mar 10, 2026

Esperion Therapeutics Q4 2025 earnings preview - MSN

Mar 10, 2026